TREA

Katrina Lee Jackson

Follow

Person

  • Cambridge, MA, US
People

Patents Grantslast 30 patents

  • Information Patent Grant

    Compounds for targeted degradation of BRD9
    • Patent number 12,049,464
    • Issue date Jul 30, 2024
    • C4 Therapeutics, Inc.
    • Christopher G. Nasveschuk
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 12,005,127
    • Issue date Jun 11, 2024
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 11,813,267
    • Issue date Nov 14, 2023
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Compounds for targeted degradation of BRD9
    • Patent number 11,691,972
    • Issue date Jul 4, 2023
    • C4 Therapeutics, Inc.
    • Christopher G. Nasveschuk
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 11,021,465
    • Issue date Jun 1, 2021
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 11,008,305
    • Issue date May 18, 2021
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Substituted quinoxaline DNA-PK inhibitors
    • Patent number 10,973,830
    • Issue date Apr 13, 2021
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 10,786,512
    • Issue date Sep 29, 2020
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 10,501,439
    • Issue date Dec 10, 2019
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 10,442,791
    • Issue date Oct 15, 2019
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 10,391,095
    • Issue date Aug 27, 2019
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 10,258,627
    • Issue date Apr 16, 2019
    • Vertex Pharmaceutical Incorporated
    • John Patrick Maxwell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 10,076,521
    • Issue date Sep 18, 2018
    • Vertex Pharamceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Substituted benzooxadiazole DNA-PK inhibitors
    • Patent number 9,987,284
    • Issue date Jun 5, 2018
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors and uses thereof
    • Patent number 9,925,188
    • Issue date Mar 27, 2018
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors for treatment of cancer
    • Patent number 9,878,993
    • Issue date Jan 30, 2018
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 9,592,232
    • Issue date Mar 14, 2017
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 9,376,448
    • Issue date Jun 28, 2016
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 9,359,380
    • Issue date Jun 7, 2016
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Substituted quinoxaline DNA-PK inhibitors
    • Patent number 9,340,557
    • Issue date May 17, 2016
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 9,296,701
    • Issue date Mar 29, 2016
    • Vertex Pharmaceuticals Incorporated
    • Paul S Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

  • Information Patent Application

    SELECTED COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
    • Publication number 20240245677
    • Publication date Jul 25, 2024
    • C4 Therapeutics, Inc.
    • Katrina L. Jackson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF
    • Publication number 20240199581
    • Publication date Jun 20, 2024
    • C4 Therapeutics, Inc.
    • Christopher G. Nasveshuk
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
    • Publication number 20240051953
    • Publication date Feb 15, 2024
    • C4 Therapeutics, Inc.
    • Christopher G. Nasveschuk
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED...
    • Publication number 20230372496
    • Publication date Nov 23, 2023
    • C4 Therapeutics, Inc.
    • Christopher G. Nasveschuk
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS
    • Publication number 20230277547
    • Publication date Sep 7, 2023
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    BRAF DEGRADERS
    • Publication number 20230145336
    • Publication date May 11, 2023
    • C4 Therapeutics, Inc.
    • Christopher G. Nasveschuk
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
    • Publication number 20230060334
    • Publication date Mar 2, 2023
    • C4 Therapeutics, Inc.
    • Christopher G. Nasveschuk
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    TARGETED PROTEIN DEGRADATION
    • Publication number 20220372016
    • Publication date Nov 24, 2022
    • C4 Therapeutics, Inc.
    • Andrew J. Phillips
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
    • Publication number 20220098194
    • Publication date Mar 31, 2022
    • C4 Therapeutics, Inc.
    • Christopher G. Nasveschuk
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS
    • Publication number 20210236505
    • Publication date Aug 5, 2021
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    COMPOUNDS FOR THE DEGRADATION OF BRD9 OR MTH1
    • Publication number 20210198256
    • Publication date Jul 1, 2021
    • C4 Therapeutics, Inc.
    • Christopher G. Nasveschuk
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20210069203
    • Publication date Mar 11, 2021
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20200353101
    • Publication date Nov 12, 2020
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick MAXWELL
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20200109130
    • Publication date Apr 9, 2020
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20200062732
    • Publication date Feb 27, 2020
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20190290654
    • Publication date Sep 26, 2019
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20190255062
    • Publication date Aug 22, 2019
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20180325898
    • Publication date Nov 15, 2018
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20180311254
    • Publication date Nov 1, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    1,3-SUBSTITUTED PYRAZOLE COMPOUNDS USEFUL FOR REDUCTION OF VERY LON...
    • Publication number 20180251431
    • Publication date Sep 6, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20180208579
    • Publication date Jul 26, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20180193341
    • Publication date Jul 12, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20180161336
    • Publication date Jun 14, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20170258789
    • Publication date Sep 14, 2017
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20160368899
    • Publication date Dec 22, 2016
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20160354381
    • Publication date Dec 8, 2016
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20160340341
    • Publication date Nov 24, 2016
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20160250212
    • Publication date Sep 1, 2016
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20150111871
    • Publication date Apr 23, 2015
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20140275059
    • Publication date Sep 18, 2014
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE